Saint-Laurent, QC
Shire Pharmaceuticals Group plc (Shire) is a global pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the worlds key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US.
2250, BOUL. ALFRED-NOBEL, BUREAU 500
Saint-Laurent, QC H4S 2C9
CA
2250, BOUL. ALFRED-NOBEL, BUREAU 500
Saint-Laurent, QC H4S 2C9
CA
Legal Name: Shire BioChem inc.
Number of Employees: 75
Agrylin has been introduced in Canada in 1998 for the treatment of essential thrombocythaemia, a chronic disorder associated with increased or abnormal production of blood platelets.
Wake promoting agent in narcolepsy
Vitamin D analog for the treatment of secondary hyperparathyroidism in patients undergoing dialysis.
Lamivudine has also been shown to be effective in treating patients with chronic Hepatatis B infection and is available as HEPTOVIR for this indication. In an agreement similar to that for lamivudine in HIV/AIDS, Shire receives royalties on sales, except in Canada where we have a business partnership with GSK.
PERMAX (pergolide mesylate), a synthetic ergot derivative, is a dopamine receptor agonist at both D1 and D2 receptor sites. PERMAX (pergolide mesylate) is indicated in the treatment of the signs and symptoms of idiopathic Parkinsons disease. PERMAX (pergolide mesylate) may be used both as early therapy, without concomitant levodopa, and as an adjunct to levodopa (usually with a peripheral decarboxylase inhibitor).
ZANAFLEX (tizanidine hydrochloride) is an agonist at 2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. ZANAFLEX (tizanidine hydrochloride) is a short-acting drug for the management of spasticity.
325410
Argentina